Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Cysteine:1D-myo-inosityl 2-amino-2-deoxy--D-glucopyranoside ligase MshC | 0.3234 | 0.5 | 0.5 |
Mycobacterium ulcerans | cysteinyl-tRNA synthetase | 0.3234 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ID50 (functional) | > 3 uM | Antiproliferative activity against lymphoid leukemia L1210 cells after 48 hr exposure. | ChEMBL. | 6631917 |
ID50 (functional) | > 3 uM | Antiproliferative activity against lymphoid leukemia L1210 cells after 48 hr exposure. | ChEMBL. | 6631917 |
ILS (functional) | = 0 % | Increase in life span of mice with lymphocytic leukemia P388 10E6 tumor cell implant (intraperitoneally) at the highest nontoxic dose of 300 mg/kg tested | ChEMBL. | 6631917 |
ILS (functional) | = 0 % | Increase in life span of mice with lymphocytic leukemia P388 10E6 tumor cell implant (intraperitoneally) at the highest nontoxic dose of 300 mg/kg tested | ChEMBL. | 6631917 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.